Role of IL-6 and TNF in thermoregulation and survival during sepsis in mice

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 275, Issue 1 44-1, 1998, Pages

  Leon, Lisa R ^a,b   White, Andrew A ^a   Kluger, Matthew J ^a  

^a LOVELACE RESPIRATORY RESEARCH INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

Acute phase response; Anorexia; Cecal ligation and puncture; Fever; Hypothermia

Indexed keywords

INTERLEUKIN 6; SEX HORMONE; TUMOR NECROSIS FACTOR;

ARTICLE; BACTERIAL INFECTION; BODY TEMPERATURE; CACHEXIA; DATA ANALYSIS; FEVER; GENOTYPE; HYPOTHERMIA; HYPOTHESIS; KNOCKOUT MOUSE; LIGATION; PRIORITY JOURNAL; PUNCTURE; SEPSIS; STATISTICAL ANALYSIS; SURVIVAL RATE; THERMOREGULATION;

EID: 0031868366     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.1998.275.1.r269     Document Type: Article

References (32)

1. Aderka, D., L. Junming, and J. Vilcek. IL-6 inhibits lipopolysaccharide-induced tumor necrosis factor production in cultured human monocytes, U937 cells, and in mice. J. Immunol. 143: 3517-3523, 1989.
2. Alexander, H. R., B. C. Sheppard, J. C. Jensen, H. N. Langstein, C. M. Buresh, D. Venzon, E. C. Walker, D. L. Fraker, M. C. Stovroff, and J. A. Norton. Treatment with recombinant human tumor necrosis factor-alpha protects rats against the lethality, hypotension, and hypothermia of gram-negative sepsis. J. Clin. Invest. 88: 34-39, 1991.
3. Bauss, F., W. Droge, and D. N. Mannel. Tumor necrosis factor mediates endotoxic effects in mice. Infect. Immun. 55: 1622-1625, 1987.
4. Bone, R. C., C. J. Fisher, T. D. Clemmer, G. J. Slotman, C. A. Metz, and R. A. Balk. Sepsis syndrome: a valid clinical entity. Crit. Care Med. 17: 389-393, 1989.
5. Casey, L. C., R. A. Balk, and R. C. Bone. Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann. Intern. Med. 119: 771-778, 1993.
6. Chai, Z., S. Gatti, C. Toniatti, V. Poli, and T. Bartfai. Interleukin (IL)-6 gene expression in the central nervous system is necessary for fever response to lipopolysaccharide or IL-1β: a study on IL-6-deficient mice. J. Exp. Med. 183: 311-316, 1996.
7. Damas, P., D. Ledoux, M. Nys, Y. Vrindts, D. de Groote, P. Franchimont, and M. Lamy. Cytokine serum level during severe sepsis in human IL-6 as a marker of severity. Ann. Surg. 215: 356-362, 1992.
8. De Waal Malefyt, R., J. Abrams, B. Bennett, C. G. Figdor, and J. E. deVries. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 174: 1209-1220, 1991.
9. Fattori, E., M. Cappelletti, P. Costa, C. Sellitto, L. Cantoni, M. Carelli, R. Faggioni, G. Fantuzzi, P. Ghezzi, and V. Poli. Defective inflammatory response in interleukin 6-deficient mice. J. Exp. Med. 180: 1243-1250, 1994.
10. Gerard, C., C. Bruyns, A. Marchant, D. Abramowicz, P. Vandenabeele, A. Delvaux, W. Fiers, M. Goldman, and T. Velu. Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J. Exp. Med. 177: 547-550, 1993.
11. Howard, M., T. Muchamuel, S. Andrade, and S. Menon. Interleukin 10 protects mice from lethal endotoxemia. J. Exp. Med. 177: 1205-1208, 1993.
12. Kozak, W., C. A. Conn, J. J. Klir, G. H. W. Wong, and M. J. Kluger. TNF soluble receptor and antiserum against TNF enhance lipopolysaccharide fever in mice. Am. J. Physiol. 269 (Regulatory Integrative Comp. Physiol. 38): R23-R29, 1995.
13. Kozak, W., V. Poli, D. Soszynski, C. A. Conn, L. R. Leon, and M. J. Kluger. Sickness behavior in mice deficient in interleukin-6 during turpentine abscess and influenza pneumonitis. Am. J. Physiol. 272 (Regulatory Integrative Comp. Physiol. 41): R621-R630, 1997.
14. Leon, L. R., W. Kozak, J. Peschon, and M. J. Kluger. Exacerbated febrile responses to LPS, but not turpentine, in TNF double receptor-knockout mice. Am. J. Physiol. 272 (Regulatory Integrative Comp. Physiol. 41): R563-R569, 1997.
15. Lundblad, R., P. Ekstrom, and K.-E. Giercksky. Pentoxifylline improves survival and reduces tumor necrosis factor, interleukin-6, and endothelin-1 in fulminant intra-abdominal sepsis in rats. Shock 3: 210-215, 1995.
16. McGowan, J. E., M. W. Barnes, and N. Finland. Bacteremia at Boston City Hospital: occurrence and mortality during 12 selected years (1935-1972) with special reference to hospital-acquired cases. J. Infect. Dis. 132: 316-335, 1975.
17. Morimoto, A., T. Ono, T. Watanabe, and N. Murakami. Fever in rats during normal and dehydrated conditions. J. Appl. Physiol. 61: 2060-2066, 1986.
18. Morrow, L. E., J. L. McClellan, C. A. Conn, and M. J. Kluger. Glucocorticoids alter fever and IL-6 responses to psychological stress and to lipopolysaccharide. Am. J. Physiol. 264 (Regulatory Integrative Comp. Physiol. 33): R1010-R1016, 1993.
19. Mozes, T., S. Ben-Efraim, C. J. A. M. Tak, J. P. C. Heiligers, P. R. Saxena, and I. L. Bonta. Serum levels of tumor necrosis factor determine the fatal or non-fatal course of endotoxic shock. Immunol. Lett. 27: 157-162, 1991.
20. Murakami, N., and T. Ono. Sex-related differences in fever development of rats. Am. J. Physiol. 252 (Regulatory Integrative Comp. Physiol. 21): R284-R289, 1987.
21. O'Riordain, M. G., D. S. O'Riordain, R. G. Molloy, J. A. Mannick, and M. L. Rodrick. Dosage and timing of anti-TNF-α antibody treatment determine its effect on resistance to sepsis after injury. J. Surg. Res. 64: 95-101, 1996.
22. Patel, R. T., K. I. Deen, D. Youngs, J. Warwick, and M. R. B. Keighley. Interleukin 6 is a prognostic indicator of outcome in severe intra-abdominal sepsis. Br. J. Surg. 81: 1306-1308, 1994.
23. Peschon, J. J., D. S. Torrance, K. L. Stocking, M. B. Glaccum, C. Otten, C. R. Willis, D. Charrier, P. J. Morrissey, C. B. Ware, and K. M. Mohler. TNF receptor-deficient mice reveal divergent roles for p55 and p75 in several models of inflammation. J. Immunol. 160: 943-952, 1998.
24. Poli, V., R. Balena, E. Fettori, A. Markatos, M. Yamamoto, H. Tanaka, G. Ciliberto, G. A. Rodan, and F. Constantini. Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion. EMBO J. 13: 1189-1196, 1994.
25. Remick, D., P. Manohar, G. Bolgos, J. Rodriguez, L. Moldawer, and G. Wollenberg. Blockade of tumor necrosis factor reduces lipopolysaccharide lethality, but not lethality of cecal ligation and puncture. Shock 4: 89-95, 1995.
26. Schobitz, F., G. Pezeshki, T. Pohl, U. Hemmann, P. C. Heinrich, F. Holsboer, and J. M. H. M. Reul. Soluble interleukin-6 (IL-6) receptor augments central effects of IL-6 in vivo. FASEB J. 9: 659-664, 1995.
27. Shih, S. T., O. Khorram, J. M. Lipton, and S. M. McCann. Central administration of α-MSH antiserum augments fever in the rabbit. Am. J. Physiol. 250 (Regulatory Integrative Comp. Physiol. 19): R803-R806, 1986.
28. Silva, A. T., K. F. Bayston, and J. Cohen. Prophylactic and therapeutic effects of a monoclonal antibody to tumor necrosis factor-α in experimental gram-negative shock. J. Infect. Dis. 162: 421-427, 1990.
29. Strassman, G., M. Fong, S. Windsor, and R. Neta. The role of interleukin-6 in lipopolysaccharide-induced weight loss, hypoglycemia and fibrinogen production, in vivo. Cytokine 5: 285-290, 1993.
30. Tracey, K. J., and B. Beutler. Shock and tissue injury induced by recombinant human cachectin. Science 234: 470-473, 1986.
31. Van der Poll, T., C. V. Keogh, D. Helfgott, L. Berman, W. A. Buurman, and S. F. Lowry. Effects of anti-interleukin 6 on inflammatory responses during murine septic peritonitis. J. Endotoxin Res. 3: 463-470, 1996.
32. Zellweger, R., M. W. Wichmann, A. Ayala, S. Stein, C. M. DeMaso, and I. H. Chaudry. Females in proestrus state maintain splenic immune functions and tolerate sepsis better than males. Crit. Care Med. 25: 106-110, 1997.